XML 103 R87.htm IDEA: XBRL DOCUMENT v3.6.0.2
Out-License of MARQIBO, ZEVALIN, & EVOMELA in China Territory - Schedule of Proceeds Received and Fair Value on CASI Out-License Execution Date (Detail) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
1 Months Ended 12 Months Ended
Sep. 17, 2014
Oct. 31, 2016
Jul. 31, 2016
Feb. 29, 2016
Dec. 31, 2016
Secured Promissory Note Due March 17, 2016 [Member]          
Other Commitments [Line Items]          
Debt instrument face value $ 1,500        
CASI Out-License [Member]          
Other Commitments [Line Items]          
Total consideration received $ 9,959        
Shares received (shares) 5.4 1.8 1.1 1.7 10.0
Stock price on the NASDAQ Capital Market ($ per share) $ 1.6        
CASI Out-License [Member] | Secured Promissory Note Due March 17, 2016 [Member]          
Other Commitments [Line Items]          
Total consideration received $ 1,310        
Debt instrument coupon rate 0.50%        
CASI Out-License [Member] | Common Stock [Member]          
Other Commitments [Line Items]          
Total consideration received $ 8,649        
Other Assets [Member] | CASI Out-License [Member] | Common Stock [Member]          
Other Commitments [Line Items]          
Value of securities         $ 11,500